¿Cómo se comparó el EPS reciente de PRVCF con las expectativas?
¿Cómo fue el desempeño de los ingresos de Preveceutical Medical Inc PRVCF en el último trimestre?
¿Cuál es la estimación de ingresos para Preveceutical Medical Inc?
¿Cuál es la puntuación de calidad de ganancias de Preveceutical Medical Inc?
¿Cuándo informa Preveceutical Medical Inc sus ganancias?
¿Cuáles son las ganancias esperadas de Preveceutical Medical Inc?
¿Superó Preveceutical Medical Inc las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$0.0172
Precio de apertura
$0.0179
Rango del día
$0.0172 - $0.0179
Rango de 52 semanas
$0.0037 - $0.0436
Volumen
15.0K
Volumen promedio
58.9K
EPS (TTM)
0.00
Rendimiento de dividendos
--
Cap. de mercado
$10.2M
¿Qué es PRVCF?
Preveceutical Medical Inc is a CA-based company operating in industry. The company is headquartered in West Vancouver, British Columbia. The company went IPO on 2016-12-30. PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, and BSV Peptide Program. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury). Its Nature Identical peptides used for treatment of various ailments. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity.